Catherine Hanaway, a member of WashU’s Board of Trustees, has been appointed to serve as Missouri attorney general. As such, Hanaway will step down from the board. She will be sworn in Sept. 8.
In a new study, WashU Medicine researchers shed light on how newly acquired mutations in blood stem cells interact with mutations passed down by parents to influence a person’s lifetime risk of developing blood cancer. The findings could inform early detection and prevention strategies.
Mikhail Tikhonov, an associate professor of physics in Arts & Sciences, is using mathematical tools to deepen our understanding of microbial ecology and evolution.
The Black Rep will launch its 49th season with “Raisin,” a lost “treasure of musical theatre” (New York Times) based on Lorraine Hansberry’s iconic family drama.
Alexander Chamessian, MD, PhD, an assistant professor of anesthesiology at WashU Medicine, was one of two early-career leaders chosen for this year’s Rita Allen Foundation Scholars Award in Pain.
Olin Business School at Washington University in St. Louis has received a landmark $10 million dual-purpose gift from longtime university benefactors Jerry and Judy Kent to create an endowed deanship and to propel the school’s Business of Health initiative.
Beginning Thursday, Aug. 21, the WashU Mobile app will be retired as part of a planned transition to a suite of specialized mobile applications designed to provide direct access to the services that students, faculty and staff use the most.
WashU Medicine postdoctoral researchers Wesley Saintilnord and Matthew Reynolds have been named Jane Coffin Childs Fellows. The fellowship is designed to support the most promising postdoctoral scientists as they seek to advance research into the causes and treatments of human disease.
A new study from WashU Medicine researchers identifies possible ways to make cancer drugs called PARP inhibitors more effective, including potential strategies to re-establish their effectiveness in tumors that develop resistance to this treatment.
